Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis

Siyu Chen,Aimei Li,Jianjiang Wu,Yidan Huang,Tiantian Zou,Taiwangu Tailaiti,Jiang Wang

DOI: https://doi.org/10.1186/s12871-022-01825-z

IF: 2.376

2022-09-16

BMC Anesthesiology

Abstract:Reperfusion of ischemic tissue has adverse impact on the myocardium. Dexmedetomidine (Dex) is a α2-adrenergic receptor (α2-AR) agonist with sedative and analgesic effects. Macrophage migration inhibition factor (MIF) is a pressure-regulating cytokine and is responsible for inflammatory and immune diseases. This study aims to reveal the consequences of Dex on myocardial ischemia-reperfusion injury (IRI) in young mice.

anesthesiology